Login

Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia 00:00:00

Share On Facebook Share On Twitter

$4-bil market opportunity in dyskinesia

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Michael Klein, Chairman & CEO of iCAD, Inc., discusses corporate highlights, uniqueness, and future plans for compounding success during an interview with SNNLive.|Michael Klein, Chairman & CEO of iCAD, Inc
00:10:00
Owen Fitzpatrick of Aristotle Atlantic Partners Shares 2018 Mid-Year Market Insights on AssetTV
00:10:00
Abiding commitment to public service that dates back for decades|Harrison J Buzz Frahn,Partner,Simpson Thacher
00:10:00
Investment Banking Technicals Mock Interview with Ziad and Devon | EarlyAdmit
00:10:00
Cesar Gon, CEO of CI&T, says 'We are living through a technological revolution' in O Globo.
00:10:00
SiTime CEO Rajesh Vashist joins Jill Malandrino on Nasdaq #TradeTalks to discuss the precision timing category and its impact.
00:10:00
Tim Levy, Managing Director of Family Zone Cyber Safety (ASX:FZO), discusses insights and updates at the TechKnow Invest Roadshow.
00:10:00
The Clarity Formula®: Prioritizing What Matters Most | Greg Heller - Founder & CEO of HCR Wealth Advisors
00:10:00
leading fund investing in passionate Asian and Pacific Islander entrepreneurs|Bing Chen,Executive Chairman,Gold House Ventures
00:10:00
Centry Financial Advisors: Estate Planning Insights | Janice Cackowski, President, Centry Financial Advisors, LLC.
00:10:00
The 5 Investment Risks for 2023: Insights from Thys van Zyl | Thys van Zyl, CEO, Everest Wealth Management, LLC.
00:10:00
Yoav Stern, CEO of Nano Dimension, discusses the acquisition of NanoFabrica to advance precision additive manufacturing technologies.|Yoav Stern, CEO of Nano Dimension

© 2026 Nehu